|
1
|
Bray F, Laversanne M, Sung H, Ferlay J,
Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics
2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J Clin. 74:229–263. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bhatla N, Aoki D, Sharma DN and
Sankaranarayanan R: Cancer of the cervix uteri. Int J Gynecol
Obstet. 143:22–36. 2018. View Article : Google Scholar
|
|
4
|
Benedet J, Pecorelli S, Ngan H and Hacker
N: Staging classifications and clinical practice guidelines for
gynaecological cancers. Int J Gynecol Obstet. 70:207–312. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pecorelli S, Zigliani L and Odicino F:
Revised FIGO staging for carcinoma of the cervix. Int J Gynecol
Obstet. 105:107–108. 2009. View Article : Google Scholar
|
|
6
|
Querleu D, Cibula D and Abu-Rustum NR:
2017 update on the Querleu-Morrow classification of radical
hysterectomy. Ann Surg Oncol. 24:3406–3412. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cibula D, Pötter R, Planchamp F,
Avall-Lundqvist E, Fischerova D, Haie-Meder C, Köhler C, Landoni F,
Lax S, Lindegaard JC, et al: The European Society of Gynaecological
Oncology/European Society for Radiotherapy and Oncology/European
Society of Pathology guidelines for the management of patients with
cervical cancer. Virchows Arch. 472:919–936. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Peters III WA, Liu P, Barrett II RJ, Stock
RJ, Monk BJ, Berek JS, Souhami L, Grigsby P, Gordon W Jr and
Alberts DS: Concurrent chemotherapy and pelvic radiation therapy
compared with pelvic radiation therapy alone as adjuvant therapy
after radical surgery in high-risk early-stage cancer of the
cervix. J Clin Oncol. 18:1606–1613. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dostalek L, Åvall-Lundqvist E, Creutzberg
CL, Kurdiani D, Ponce J, Dostalkova I and Cibula D: ESGO survey on
current practice in the management of cervical cancer. Int J
Gynecol Cancer. 28:1226–1231. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Monk BJ, Wang J, Im S, Stock RJ, Peters WA
III, Liu PY, Barrett RJ II, Berek JS, Souhami L, Grigsby PW, et al:
Rethinking the use of radiation and chemotherapy after radical
hysterectomy: A clinical-pathologic analysis of a gynecologic
oncology Group/Southwest oncology Group/Radiation therapy oncology
group trial. Gynecol Oncol. 96:721–728. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sedlis A, Bundy BN, Rotman MZ, Lentz SS,
Muderspach LI and Zaino RJ: A randomized trial of pelvic radiation
therapy versus no further therapy in selected patients with stage
IB carcinoma of the cervix after radical hysterectomy and pelvic
lymphadenectomy: A gynecologic oncology group study. Gynecol Oncol.
73:177–183. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cibula D: Early-stage
intermediate-risk-the group with the most heterogenous management
among patients with cervical cancer. Int J Gynecol Cancer.
32:1227–1228. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wright JD, Matsuo K, Huang Y, Tergas AI,
Hou JY, Khoury-Collado F, St Clair CM, Ananth CV, Neugut AI and
Hershman DL: Prognostic performance of the 2018 International
Federation of Gynecology and Obstetrics cervical cancer staging
guidelines. Obstet Gynecol. 134:49–57. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cibula D, Akilli H, Jarkovsky J, van
Lonkhuijzen L, Scambia G, Meydanli MM, Ortiz DI, Falconer H,
Abu-Rustum NR, Odetto D, et al: Role of adjuvant therapy in
intermediate-risk cervical cancer patients-Subanalyses of the SCCAN
study. Gynecol Oncol. 170:195–202. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kurman RJ, Carcangiu ML and Herrington CS:
WHO Classification of Tumours of Female Reproductive Organs. 4th
Edition. IARC Publications; Lyon: 2014
|
|
16
|
Rotman M, Sedlis A, Piedmonte MR, Bundy B,
Lentz SS, Muderspach LI and Zaino RJ: A phase III randomized trial
of postoperative pelvic irradiation in Stage IB cervical carcinoma
with poor prognostic features: Follow-up of a gynecologic oncology
group study. Int J Radiat Oncol Biol Phys. 65:169–176. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Peters WA III, Liu P, Barrett II RJ, Stock
RJ, Monk BJ, Berek JS, Souhami L, Grigsby P, Gordon W Jr and
Alberts DS: Concurrent chemotherapy and pelvic radiation therapy
compared with pelvic radiation therapy alone as adjuvant therapy
after radical surgery in high-risk early-stage cancer of the
cervix. J Clin Oncol. 18:1606–1613. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cao L, Wen H, Feng Z, Han X, Zhu J and Wu
X: Role of adjuvant therapy after radical hysterectomy in
intermediate-risk, early-stage cervical cancer. Int J Gynecol
Cancer. 31:52–58. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nasioudis D, Latif NA, Giuntoli II RL,
Haggerty AF, Cory L, Kim SH, Morgan MA and Ko EM: Role of adjuvant
radiation therapy after radical hysterectomy in patients with stage
IB cervical carcinoma and intermediate risk factors. Int J Gynecol
Cancer. 31:829–834. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kissel M, Balaya V, Guani B, Magaud L,
Mathevet P and Lécuru F; SENTICOL group, : Impact of preoperative
brachytherapy followed by radical hysterectomy in stage IB2 (FIGO
2018) cervical cancer: An analysis of SENTICOL I–II trials. Gynecol
Oncol. 170:309–316. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen X, Duan H, Liu P, Lin L, Ni Y, Li D,
Dai E, Zhan X, Li P, Huo Z, et al: Development and validation of a
prognostic nomogram for 2018 FIGO stages IB1, IB2, and IIA1
cervical cancer: A large multicenter study. Ann Transl Med.
10:1212022. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhu J, Cao L, Wen H, Bi R, Wu X and Ke G:
The clinical and prognostic implication of deep stromal invasion in
cervical cancer patients undergoing radical hysterectomy. J Cancer.
11:7368–7377. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kim SI, Cho JH, Seol A, Kim YI, Lee M, Kim
HS, Chung HH, Kim JW, Park NH and Song YS: Comparison of survival
outcomes between minimally invasive surgery and conventional open
surgery for radical hysterectomy as primary treatment in patients
with stage IB1-IIA2 cervical cancer. Gynecol Oncol. 153:3–12. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ryu S, Kim M, Nam B, Lee TS, Song ES, Park
CY, Kim JW, Kim YB and Ryu HS: Intermediate-risk grouping of
cervical cancer patients treated with radical hysterectomy: A
Korean Gynecologic Oncology Group study. Br J Cancer. 110:278–285.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Takeshima N, Umayahara K, Fujiwara K,
Hirai Y, Takizawa K and Hasumi K: Treatment results of adjuvant
chemotherapy after radical hysterectomy for intermediate-and
high-risk stage IB-IIA cervical cancer. Gynecol Oncol. 103:618–622.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li L, Song X, Liu R, Li N, Zhang Y, Cheng
Y, Chao H and Wang L: Chemotherapy versus radiotherapy for FIGO
stages IB1 and IIA1 cervical carcinoma patients with postoperative
isolated deep stromal invasion: A retrospective study. BMC Cancer.
16:4032016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Moon SH, Wu HG, Ha SW, Lee HP, Kang SB,
Song YS, Park NH, Kim JW, Park IA and Kim BH: Isolated
full-thickness cervical stromal invasion warrants post-hysterectomy
pelvic radiotherapy in FIGO stages IB-IIA uterine cervical
carcinoma. Gynecol Oncol. 104:152–157. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Herrington CS: WHO Classification of
Tumours Female Genital Tumours. IARC Publications; Lyon: 2020
|
